COVID Clinical Trials 2024

COVID Clinical Trials 2024

COVID research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in covid-19 clinical trials today.

COVID Clinical Trials

Here are the 6 most popular medical studies for covid

Popular filter options for covid trials

Coronavirus Clinical Trials

View 71 Coronavirus medical studies.

Acute Respiratory Distress Syndrome Clinical Trials

View 10 Acute Respiratory Distress Syndrome medical studies.

Phase 3 Covid Clinical Trials

View 99 phase 3 covid medical studies.

Covid Clinical Trials With No Placebo

View 99 covid medical studies that do not have a placebo group.

View More Covid Trials

See another 73 medical studies focused on covid.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to covid

What are the top hospitals conducting covid research?

In the global battle against COVID-19, top hospitals have emerged as beacons of hope and innovation. One such institution is the University of Rochester Medical Center in Rochester, New york. Despite their relatively small number of active COVID trials (3) and all-time trials (2), this hospital has made significant strides since recording its first trial in 2020. Similarly, the University of South Florida in Tampa has dedicated itself to finding effective solutions with three ongoing COVID trials and a history of two previous studies. Both these facilities have demonstrated their commitment to pushing boundaries and exploring new avenues for treatment.

Meanwhile, Hennepin County Medical Center located in Minneapolis has also stepped up to face this unprecedented challenge head-on. With three active COVID trials underway and four completed studies under its belt, this medical center stands at the forefront of innovative research within their community since initiating their inaugural trial last year.

The University of Minnesota - another prominent institution nestled in Minneapolis - joins forces by conducting three concurrent clinical trials focused on combating COVID-19 while boasting an impressive ten past investigations centered around the virus's impact on public health; they too started contributing towards understanding it from 2020 onwards.

Notably making an appearance among these renowned hospitals is Massachusetts General Hospital situated in Boston—the city rich with medical excellence—where doctors and researchers are actively engaged in three cutting-edge clinical trials aimed at conquering the pandemic that has gripped our world tightly. Having previously conducted five additional studies related to COVID-19 since embarking on research endeavors just last year.

These hospitals exemplify unwavering dedication and perseverance in tackling the current crisis. The incredible work being done across these institutions signifies extraordinary collaboration between healthcare professionals, scientists, volunteers, patients, who collectively strive for a brighter future amidst uncertain times

Which are the best cities for covid clinical trials?

When it comes to COVID clinical trials, several cities stand out as leaders in research and development. Houston, Texas leads the way with 27 active trials focusing on mRNA-1273 and Biological/Vaccine: BNT162b2 3mcg among others. Miami, Florida follows closely behind with 20 ongoing studies exploring PBI-0451 (Pomotrelvir) and Niclosamide, among other treatments. New york, New York also plays a significant role with 18 active trials investigating various treatment options like Cohort B, Arm B2P: BNT162b2 and Therapeutic Dose Anticoagulation + P2Y12 inhibitor. Additionally, Los Angeles, California and Atlanta, Georgia have notable contributions to COVID clinical trials with their respective studies on ritonavir and Biological/Vaccine: BNT162b2 3mcg. These cities collectively provide individuals affected by COVID access to cutting-edge clinical trials that pave the way for advancements in care and potential breakthroughs in combating the virus.

Which are the top treatments for covid being explored in clinical trials?

Clinical trials are actively investigating potential treatments for COVID-19, with several options showing promise. Hydroxychloroquine is currently being explored in two active trials and has been part of 22 clinical trials overall since its first listing in 2020. Another treatment gaining attention is VBI-2901a, which has one ongoing trial and was introduced to COVID research in 2022. These treatments offer hope as researchers work diligently to combat the impact of this global pandemic.

What are the most recent clinical trials for covid?

Exciting advancements are underway in the field of COVID-19 research, with recent clinical trials offering potential breakthroughs in our fight against this global pandemic. Noteworthy studies include Group i, a Phase 4 trial that aims to evaluate the effectiveness of a specific intervention for COVID-19 patients. Additionally, an inspiring Phase 1 trial investigates the use of allogeneic mesenchymal stromal cells as a treatment option for COVID-19. Another significant study involves individuals who have undergone solid organ transplants and examines their response to COVID-19 treatments in a Phase 2 trial. Further progress can be seen through Group 2 and Active, both undergoing Phase 2 trials to assess their efficacy in combatting this infectious disease. With these diverse approaches being investigated, there is hope on the horizon for improved outcomes and ultimately overcoming the challenges posed by COVID-19.

What covid clinical trials were recently completed?

Several clinical trials focusing on COVID-19 have recently concluded, representing vital steps forward in our fight against the pandemic. In August 2021, Merck Sharp & Dohme Corp. completed a trial for Molnupiravir, while Janssen Vaccines & Prevention B.V.'s Ad26.COV2.S trial also reached completion during the same month. Earlier in July 2021, James L. Kirkland's Fisetin study made significant progress as well. These trials build upon the substantial research conducted to combat COVID-19 and provide valuable insights into potential treatments and preventive measures.